CovidChloroV1, Main, Corpus, bibRecord, 000F68

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.

Identifieur interne : 000F68 ( Main/Corpus ); précédent : 000F67; suivant : 000F69

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.

Auteurs : Manuel Francisco Ugarte-Gil ; Maximilian F. Konig ; Peter Korsten ; Francis Berenbaum ; Alfred Hyoungju Kim ; Jeffrey A. Sparks

Source :

Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.

RBID : pubmed:32759257
DOI: 10.1136/annrheumdis-2020-218683
PubMed: 32759257
PubMed Central: PMC8075121

Links to Exploration step

pubmed:32759257

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer <i>et al</i>
.</title>
<author><name sortKey="Ugarte Gil, Manuel Francisco" sort="Ugarte Gil, Manuel Francisco" uniqKey="Ugarte Gil M" first="Manuel Francisco" last="Ugarte-Gil">Manuel Francisco Ugarte-Gil</name>
<affiliation><nlm:affiliation>Department of Rheumatology, Universidad Cientifica del Sur, Lima, Peru.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name>
<affiliation><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen, Gottingen, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name>
<affiliation><nlm:affiliation>Rheumatology, Sorbonne Université, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred Hyoungju" sort="Kim, Alfred Hyoungju" uniqKey="Kim A" first="Alfred Hyoungju" last="Kim">Alfred Hyoungju Kim</name>
<affiliation><nlm:affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32759257</idno>
<idno type="pmid">32759257</idno>
<idno type="doi">10.1136/annrheumdis-2020-218683</idno>
<idno type="pmc">PMC8075121</idno>
<idno type="wicri:Area/Main/Corpus">000F68</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F68</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer <i>et al</i>
.</title>
<author><name sortKey="Ugarte Gil, Manuel Francisco" sort="Ugarte Gil, Manuel Francisco" uniqKey="Ugarte Gil M" first="Manuel Francisco" last="Ugarte-Gil">Manuel Francisco Ugarte-Gil</name>
<affiliation><nlm:affiliation>Department of Rheumatology, Universidad Cientifica del Sur, Lima, Peru.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name>
<affiliation><nlm:affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Korsten, Peter" sort="Korsten, Peter" uniqKey="Korsten P" first="Peter" last="Korsten">Peter Korsten</name>
<affiliation><nlm:affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen, Gottingen, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berenbaum, Francis" sort="Berenbaum, Francis" uniqKey="Berenbaum F" first="Francis" last="Berenbaum">Francis Berenbaum</name>
<affiliation><nlm:affiliation>Rheumatology, Sorbonne Université, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, Alfred Hyoungju" sort="Kim, Alfred Hyoungju" uniqKey="Kim A" first="Alfred Hyoungju" last="Kim">Alfred Hyoungju Kim</name>
<affiliation><nlm:affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sparks, Jeffrey A" sort="Sparks, Jeffrey A" uniqKey="Sparks J" first="Jeffrey A" last="Sparks">Jeffrey A. Sparks</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32759257</PMID>
<DateRevised><Year>2021</Year>
<Month>04</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Aug</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer <i>et al</i>
.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">annrheumdis-2020-218683</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-218683</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ugarte-Gil</LastName>
<ForeName>Manuel Francisco</ForeName>
<Initials>MF</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1728-1999</Identifier>
<AffiliationInfo><Affiliation>Department of Rheumatology, Universidad Cientifica del Sur, Lima, Peru.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Konig</LastName>
<ForeName>Maximilian F</ForeName>
<Initials>MF</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-5045-5255</Identifier>
<AffiliationInfo><Affiliation>Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Korsten</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-6065-5680</Identifier>
<AffiliationInfo><Affiliation>Department of Nephrology and Rheumatology, University Medical Center Göttingen, Gottingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berenbaum</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8252-7815</Identifier>
<AffiliationInfo><Affiliation>Rheumatology, Sorbonne Université, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName>
<ForeName>Alfred Hyoungju</ForeName>
<Initials>AH</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4074-0516</Identifier>
<AffiliationInfo><Affiliation>Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y"><LastName>Sparks</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-5556-4618</Identifier>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>T32 AR048522</GrantID>
<Acronym>AR</Acronym>
<Agency>NIAMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arthritis</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">lupus erythematosus</Keyword>
<Keyword MajorTopicYN="N">rheumatoid</Keyword>
<Keyword MajorTopicYN="N">systemic</Keyword>
</KeywordList>
<CoiStatement>Competing interests: PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. AHK reports grants from National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics, Inc. and GlaxoSmithKline. Drs Liew and Graef have disclosed no conflicts of interest or competing interests. JAS reports grants from NIH/NIAMS/National Institute of Allergy and Infectious Diseases/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute, and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pmc-release"><Year>2022</Year>
<Month>02</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32759257</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-218683</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-218683</ArticleId>
<ArticleId IdType="pmc">PMC8075121</ArticleId>
<ArticleId IdType="mid">NIHMS1689933</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Ann Rheum Dis. 2020 Jun;79(6):734-736</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32295786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Oct;79(10):1386-1388</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32381561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Aug 5;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32759263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Aug;584(7821):430-436</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32640463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Sep;79(9):1170-1173</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32532753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 2020 Jul;79(7):859-866</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32471903</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Arthritis Rheum. 2020 Aug;50(4):564-570</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32425260</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Joint Bone Spine. 2020 Oct;87(5):439-443</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32445935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Sep;585(7826):588-590</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32698190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheumatol. 2020 Oct;72(10):1600-1606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32506699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F68 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000F68 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32759257
   |texte=   Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32759257" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki